Michigan has seen cases skyrocket 168% in five years, but the new vaccine candidate offers hope with strong trial results and ...

Lyme disease, a tick-borne illness, can be very difficult to diagnose early on, making it even more dangerous during peak season. According to the Centers for Disease Control and Prevention, Lyme ...

The partners said the shot produced “clinically meaningful” efficacy despite missing its main study objective, a finding they blamed on a lower-than-expected rate of infections during the trial.

Pfizer’s shot fell short of its initial trial goal, but with nearly half a million Americans infected each year, the company ...

Lyme disease rates are climbing across the country, with the Centers for Disease Control and Prevention reporting emergency room visits for tick bites reaching their highest levels in years.

If approved by regulators, it would be the only vaccine for humans against Lyme disease.

Pfizer and Valneva announce Lyme disease vaccine candidate demonstrates strong efficacy in phase 3 VALOR trial: New York Tuesday, March 24, 2026, 12:00 Hrs [IST] Pfizer Inc. and V ...

Researchers at Dartmouth Hitchcock Medical Center have developed a way to diagnose Lyme disease earlier and more accurately than traditional testing methods. Over the past 30 years, Lyme disease has ...

As the spring season sets in and the weather starts to get warmer everyone wants to go outside to hike and take in nature but ...